Bio-enteric Intragastric Balloon in Obese Patients: A Retrospective Analysis of King Faisal Specialist Hospital Experience

• Published in: Obesity surgery 2010-09, Vol.20 (9), p.1219-1226
• Main Authors: Al Kahtani, Khalid, Khan, Mohammed Qaseem, Helmy, Ahmed, Al Ashgar, Hamad, Rezeig, Mohammed, Al Quaiz, Mohammed, Kagevi, Ingvar, Al Sofayan, Mohamed, Al Fadda, Mohammed
• Format: Article
• Language: English
• Subjects: Adult; Body Mass Index; Clinical outcomes; Device Removal - adverse effects; Female; Gastric Balloon - adverse effects; Gastrointestinal surgery; Humans; Male; Medicine; Medicine & Public Health; Obesity; Obesity, Morbid - therapy; Research Article; Surgery; Surgical techniques; Transplants & implants; Weight Loss
• ISSN: 0960-8923; 1708-0428
• DOI: 10.1007/s11695-008-9654-0

Background Bio-enteric intragastric balloon (BIB) insertion is gaining popularity for weight reduction in obese patients. We evaluated the efficacy, tolerability, and safety of BIB in the treatment of obesity. Methods A total of 173 Saudi obese patients [mean±SD age 34.5 ± 11.6 years, 58 (33.5%) were men] who underwent BIB (InaMed Corporation, California, USA) insertion were followed up clinically, biochemically, and endoscopically for 6–12 months. The mean±SD baseline body weight, excess weight, and body mass index (BMI) were 123.5 ± 39.6 and 68.9 ± 40.0 kg and 46.7 ± 14.1 kg/m 2 , respectively. Associated dietary control, exercise, and medical treatment were used in 67 (38.7%), 60 (34.7%), and 3 (1.7%), respectively. Results BIBs were safely and successfully inserted in 15.1 ± 6.2 min, filled with 626.2 ± 41.7 ml methylene blue solution, removed after a period of 189.7 ± 68.3 days, within 14.1 ± 6.3 min. BIB was not tolerated for 6 months in 33 (19.8%) patients. Body weight and BMI at 6 and 12 months postinsertion were significantly reduced to 112.5 ± 35.7 kg and 43.1 ± 13.1 kg/m 2 , and 110.7 ± 34.5 kg and 42.3 ± 12.6 kg/m 2 , respectively ( p